ATE79031T1 - Verwendung von ketonderivaten zur behandlung von depressionen. - Google Patents

Verwendung von ketonderivaten zur behandlung von depressionen.

Info

Publication number
ATE79031T1
ATE79031T1 AT87311082T AT87311082T ATE79031T1 AT E79031 T1 ATE79031 T1 AT E79031T1 AT 87311082 T AT87311082 T AT 87311082T AT 87311082 T AT87311082 T AT 87311082T AT E79031 T1 ATE79031 T1 AT E79031T1
Authority
AT
Austria
Prior art keywords
ketone derivatives
treat depression
methyl
depression
treat
Prior art date
Application number
AT87311082T
Other languages
German (de)
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE79031T1 publication Critical patent/ATE79031T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
AT87311082T 1986-12-17 1987-12-16 Verwendung von ketonderivaten zur behandlung von depressionen. ATE79031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments
EP87311082A EP0276559B1 (en) 1986-12-17 1987-12-16 Use of ketone derivatives in the treatment of depression

Publications (1)

Publication Number Publication Date
ATE79031T1 true ATE79031T1 (de) 1992-08-15

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311082T ATE79031T1 (de) 1986-12-17 1987-12-16 Verwendung von ketonderivaten zur behandlung von depressionen.

Country Status (18)

Country Link
US (1) US4835173A (OSRAM)
EP (1) EP0276559B1 (OSRAM)
JP (1) JP2732844B2 (OSRAM)
KR (1) KR880007073A (OSRAM)
AT (1) ATE79031T1 (OSRAM)
AU (1) AU608794B2 (OSRAM)
CY (1) CY1693A (OSRAM)
DE (1) DE3780940T2 (OSRAM)
DK (1) DK662787A (OSRAM)
ES (1) ES2051754T3 (OSRAM)
GB (1) GB8630071D0 (OSRAM)
GR (1) GR3005682T3 (OSRAM)
HK (1) HK36593A (OSRAM)
IE (1) IE60135B1 (OSRAM)
IL (1) IL84844A0 (OSRAM)
NZ (1) NZ222949A (OSRAM)
PH (1) PH25503A (OSRAM)
ZA (1) ZA879458B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
DE3788057T2 (de) * 1986-12-17 1994-03-03 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
AU2295792A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
CA2371822A1 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
JP2004525083A (ja) * 2000-10-30 2004-08-19 テバ ファーマシューティカル インダストリーズ リミティド 塩酸オンダンセトロンの新規結晶及び溶媒和物形態並びにその製法
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
IL156835A0 (en) * 2001-01-11 2004-02-08 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
MXPA04010846A (es) * 2002-04-29 2005-01-25 Biogal Gyogyszergyar Proceso para preparar 1, 2, 3, 9-tetrahidro -9- metil-3 -[(2-metil -1h-imidazol -1-il) metil]- 4h- carbazol -4- ona.
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
CA2483532A1 (en) * 2002-04-30 2003-11-13 Biogal Gyogyszergyar Rt. Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
WO2009027564A1 (es) * 2007-08-08 2009-03-05 Legarda Ibanez Juan Jose Uso y métodos de uso de un antagonista del receptor (5-ht3) de la serotonina3 y un modulador selectivo de los canales de cloruro para el tratamiento de la adicción a o la dependencia de fármacos/drogas o trastornos del sistema nervioso central
CN112292122A (zh) 2018-06-21 2021-01-29 雀巢产品有限公司 使用烟酰胺腺嘌呤二核苷酸(nad+)前体和至少一种酮或酮前体的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (OSRAM) * 1981-06-09 1987-02-28 Ici Plc
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
NZ210940A (en) * 1984-01-25 1989-08-29 Glaxo Group Ltd 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol

Also Published As

Publication number Publication date
NZ222949A (en) 1997-06-24
IL84844A0 (en) 1988-06-30
CY1693A (en) 1994-01-14
AU8261787A (en) 1988-06-23
ZA879458B (en) 1988-11-30
EP0276559A2 (en) 1988-08-03
DK662787D0 (da) 1987-12-16
JPS63165314A (ja) 1988-07-08
KR880007073A (ko) 1988-08-26
JP2732844B2 (ja) 1998-03-30
EP0276559A3 (en) 1989-10-18
ES2051754T3 (es) 1994-07-01
GR3005682T3 (OSRAM) 1993-06-07
US4835173A (en) 1989-05-30
DE3780940D1 (de) 1992-09-10
DK662787A (da) 1988-06-18
GB8630071D0 (en) 1987-01-28
DE3780940T2 (de) 1992-12-24
IE60135B1 (en) 1994-06-01
HK36593A (en) 1993-04-23
PH25503A (en) 1991-07-24
EP0276559B1 (en) 1992-08-05
AU608794B2 (en) 1991-04-18
IE873415L (en) 1988-06-17

Similar Documents

Publication Publication Date Title
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
SE8503680D0 (sv) Indolderivat
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69022249D1 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE69431056D1 (de) Substituierte oxazolyl-derivate zur behandlung von entzündungen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
FI913818A0 (fi) Nytt trombolytiskt aemne.
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE96317T1 (de) Verwendung von 5-(subst. phenyl)oxazolidinonderivaten zur behandlung von depressionen.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
FR2676622B1 (fr) Prothese capillaire et procede de traitement des calvities au moyen de cette prothese.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
ATE91234T1 (de) Verwendung von dimetylheptylphenylbutanoylethanolamin bei der behandlung von hyperuricemie.
ATE299021T1 (de) Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
DE69001070D1 (de) Verwendung von beta-blockierungsmitteln zur behandlung der meniere-krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee